Document Detail


Secondary hyperparathyroidism and cardiac hypertrophy in hemodialysis patients.
MedLine Citation:
PMID:  2963169     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Echocardiographic assessment of left ventricular function was performed in 66, stable hemodialysis patients and 50 normal controls matched for sex, age and arterial blood pressure. On the basis of bone histology, hemodialysis patients were classified into two groups: (1) patients with normal bone resorption; and (2) patients with active secondary hyperparathyroidism characterized by an increased bone resorption. Left ventricular function of these two subgroups were compared together as well as with the echocardiographic characteristics of normal controls. In comparison with normal controls, hemodialysis patients with normal bone resorption had an increased left ventricular volume (P less than 0.001) and left ventricular mass (P less than 0.001) with a similar left ventricular mass-to-volume ratio. Their systolic arterial pressure--mass-to-volume ratio correlation was similar to that of normal controls, indicating an adequate myocardial hypertrophy. Patients with increased bone resorption had high parathormone and alkaline phosphatase levels; though the left ventricular dilation was similar to that of hemodialysis patients with normal bone resorption, the left ventricular mass was lower (P less than 0.001) and was similar to the left ventricular mass of normal controls. In addition, patients with increased bone resorption had a lower mass-to-volume ratio (P less than 0.001) and their systolic arterial pressure--mass-to-volume ratio correlation exhibited a significant downward shift (P less than 0.001), suggesting an inadequate myocardial hypertrophy. Patients with increased bone resorption and secondary hyperparathyroidism had an increased heart rate, a higher systolic arterial pressure and end-systolic stress. Furthermore, they had an increased velocity of fiber shortening (P less than 0.01) and shorter left ventricular ejection time (P less than 0.001). In summary, present data suggest the possibility that parathormone may exert myocardial effects in hemodialysis patients.
Authors:
G M London; M C De Vernejoul; F Fabiani; S J Marchais; A P Guerin; F Metivier; A M London; F Llach
Related Documents :
12122119 - The mekk1-jnk pathway plays a protective role in pressure overload but does not mediate...
3944349 - Assessment of pericardial constraint: the relation between right ventricular filling pr...
17174589 - A two phase harmonic model for left ventricular function.
893679 - Evidence for cardiomyopathy in familial diabetes mellitus.
954069 - Right ventricular mass estimation by angioechocardiography.
10619589 - Reduction in arterial distensibility in hypertensive patients as evaluated by ambulator...
8205519 - The center of pressure index in the evaluation of foot orthoses in shoes.
25233859 - Brachial vs. central systolic pressure and pulse wave transmission indicators: a critic...
20729159 - Central blood pressure measurements-an opportunity for efficacy and safety in drug deve...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Kidney international     Volume:  32     ISSN:  0085-2538     ISO Abbreviation:  Kidney Int.     Publication Date:  1987 Dec 
Date Detail:
Created Date:  1988-03-09     Completed Date:  1988-03-09     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0323470     Medline TA:  Kidney Int     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  900-7     Citation Subset:  IM    
Affiliation:
Centre Hospitalier F.H. Manhes, Fleury-Mergois, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Blood Pressure
Bone Resorption
Cardiomegaly / complications*,  physiopathology
Echocardiography
Female
Humans
Hyperparathyroidism, Secondary / complications*,  physiopathology
Male
Middle Aged
Parathyroid Hormone / blood
Renal Dialysis*
Chemical
Reg. No./Substance:
0/Parathyroid Hormone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Induction, characterization, and cell transfer of autoimmune tubulointerstitial nephritis.
Next Document:  On the role of additive hormone monotherapy with tamoxifen, medroxyprogesterone acetate and aminoglu...